Thrombotic risk minimization for Diane-35 and generics-Reference-Cited by-同舟云学术

Thrombotic risk minimization for Diane-35 and generics

Published:2017-09-26 Issue:11 Volume:26 Page:1411-1417
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Bezemer Irene D.¹^ORCID,Smits Elisabeth¹,Penning-van Beest Fernie J.A.¹,Asiimwe Alex²,Herings Ron M.C.¹³

Affiliation:

1. PHARMO Institute for Drug Outcomes Research; Utrecht The Netherlands

2. Bayer Pharma AG, Pharmaceuticals Division; Global Epidemiology; Berlin Germany

3. Department of Epidemiology & Biostatistics; VU Medical Center; Amsterdam The Netherlands

Funder

Bayer AG

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference18 articles.

1. Diane-35 SmPC (Dutch): College ter Beoordeling van Geneesmiddelen 2015 http://db.cbg-meb.nl/IB-teksten/h11903.pdf

2. Cyproterone/ethinylestradiol-containing medicines: article-107i procedure--notification: European medicines agency 2013 http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/cyproterone_ethinylestradiol_107i/Procedure_started/WC500138613.pdf

3. Hormonal contraception and risk of venous thromboembolism: national follow-up study;Lidegaard;BMJ,2009

4. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9;Lidegaard;BMJ,2011

5. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives;Vasilakis-Scaramozza;Lancet,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy;Contraception;2020-10

2. Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands;Drug Safety;2020-03-24

3. Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review;Drug Safety;2020-02-04

4. Anti-androgenic therapy in young patients and its impact on intensity of hirsutism, acne, menstrual pain intensity and sexuality — a preliminary study;Ginekologia Polska;2019-09-30